Home/Filings/4/0001127602-24-028052
4//SEC Filing

Summy Amy B. 4

Accession 0001127602-24-028052

CIK 0000920148other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 11:06 AM ET

Size

9.7 KB

Accession

0001127602-24-028052

Insider Transaction Report

Form 4
Period: 2024-11-22
Summy Amy B.
EVP, Chief Marketing Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-11-22$168.52/sh+4,015$676,6087,990 total
  • Sale

    Common Stock

    2024-11-22$238.91/sh3,671.5$877,1424,318.5 total
  • Exercise/Conversion

    Non-qualified Stock Options

    2024-11-224,0150 total
    Exercise: $168.52From: 2021-02-04Exp: 2030-02-03Common Stock (4,015 underlying)
Footnotes (4)
  • [F1]The price of $238.9055 per share represents a weighted average of sales prices ranging from $238.822 to $239.410 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • [F2]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
  • [F3]Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea.
  • [F4]The option vested in three equal annual installments beginning on the date reflected in this column.

Issuer

LABCORP HOLDINGS INC.

CIK 0000920148

Entity typeother

Related Parties

1
  • filerCIK 0001805303

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 11:06 AM ET
Size
9.7 KB